Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter. - Wikidata - awgldk - TriplyDB

Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

http://www.wikidata.org/entity/Q34202452

about

Antiplatelet agents and anticoagulants for hypertension Atrial fibrillation in a primary care practice: prevalence and management Long term anticoagulation or antiplatelet treatment. Only warfarin has been shown to reduce stroke risk in patients with atrial fibrillation.Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation.Poor adherence to anticoagulation guidelines in patients with non-valvular atrial fibrillation treated in a tertiary cardiology unit When should I stop anticoagulation for atrial fibrillation?Treatment of Atrial Fibrillation in Patients with Dementia: A Cohort Study from the Swedish Dementia Registry.

P2860

Q24246637-1048B8FC-DCF6-4499-B9A3-266AA3B2FC33 Q24795377-4222A97A-23CA-49EA-B0DA-05CF8B2A8D16 Q28187842-63E83000-350D-4027-9867-C00591B630A5 Q34561536-7CD874E3-5B36-42F9-98AF-34D72B8E7954 Q36801083-0FB6BCA2-520A-4BA8-AFA9-6F993306B612 Q43058319-3230A67A-1C7F-4991-BFC9-4F3A939AD425 Q47559889-DEBCE673-250B-4EF0-8FFB-6D7EA34989F9

P2860

Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

http://www.wikidata.org/entity/Q34202452

description

2001 nî lūn-bûn

@nan

2001 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

@ast

Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

@en

Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

@nl

type

label

Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

@ast

Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

@en

Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

@nl

prefLabel

Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

@ast

Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

@en

Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

@nl

P1433

Q34202452-09D0372F-B318-430A-B4B5-41055B914BAE

P1476

Q34202452-01493E39-5AB1-4376-9033-CBDDD51D5794

P2093

Q34202452-11B9256C-542D-43F5-A4B3-8B28F7B1C176

Q34202452-1B3D9A11-E618-4873-B4AB-91B606C29290

Q34202452-56EFFCF4-E6E9-4EC9-A73E-45258826CF83

Q34202452-8C2FC48A-10DA-40A2-A0BB-B2215D11C8AB

Q34202452-DD7892BC-46C7-466C-821F-56CE2FA90121

Q34202452-E8882494-DE62-44DC-A17D-D5E642896B0B

Q34202452-E98E4C9A-EC3C-4454-8BAA-61FD4F2B7E42

P2860

Q34202452-08B736C2-9808-4863-8197-63FFBDC9FF94

Q34202452-1E85DC80-F4CE-42EA-9C7F-6DDFFF5EFF3A

Q34202452-21425353-01A0-4CD9-9FBC-07AF75B9CC54

Q34202452-2BFE014A-0B10-4609-A19D-36C065DDDB38

Q34202452-3B85B83F-C9FA-4C3E-B975-34BFDA894CBC

Q34202452-4EC975B7-96C6-49B0-B491-3C0AA8E2985D

Q34202452-9623A703-8A5D-4C6C-AC77-0D9157459F6D

P304

Q34202452-9F4D9165-3F0F-46D3-A32F-44D8A571D1EA

P31

Q34202452-AE2BD90D-3CDC-4DC0-8DA5-A80AE3DC640E

Q34202452-fec56b70-3e0a-4336-8271-d8684995aede

P356

Q34202452-F6770DEC-654B-4AD8-9896-1A4A76331C07

P433

Q34202452-06404AAA-4C78-437A-9AF0-E4F8D4ABD939

P577

Q34202452-75956B29-FC38-41FF-A957-49294F2A9606

P698

Q34202452-2E8FB956-103A-4B07-9D24-887531411465

P921

Q34202452-CC4102CB-91B6-42C6-A6C6-B2FF83CC62F3

P356

14651858.CD001938

P1433

Cochrane Database of Systematic Reviews

P1476

Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

@en

P2093

E B Bass

http://www.w3.org/2001/XMLSchema#string

J B Segal

http://www.w3.org/2001/XMLSchema#string

K A Robinson

http://www.w3.org/2001/XMLSchema#string

M R Miller

http://www.w3.org/2001/XMLSchema#string

N R Powe

http://www.w3.org/2001/XMLSchema#string

R L McNamara

http://www.w3.org/2001/XMLSchema#string

S N Goodman

http://www.w3.org/2001/XMLSchema#string

P2860

Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin.

Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis.

Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators.

Synthesis of the literature on visual acuity and complications following cataract extraction with intraocular lens implantation. Cataract Patient Outcome Research Team.

Incidence of and risk factors for atrial fibrillation in older adults.

Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation : a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperat

Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators.

P304

CD001938

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/14651858.CD001938

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P577

2001-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11279741

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation